ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 24.79 Delayed Data As of May 26 |  +0.34 / +1.39%Today’s Change | 12.24 Today|||52-Week Range 26.04 | +55.72% Year-to-Date |
Institutional investors hold a majority ownership of ACAD through the 98.32% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $5.3 million shares.
| Other institutional | 66.69% |
| Individual stakeholders | 32.89% |
| Mutual fund holders | 31.63% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2023 | RTW INVESTMENTS LP Bought 4.6 Million shares of ACADIA Pharmaceuticals In... |
| 3/31/2023 | ADAGE CAPITAL MANAGEMENT LP Bought 1.2 Million shares of ACADIA Pharmaceuticals In... |
| 3/31/2023 | MORGAN STANLEY & CO. LLC Bought 1.1 Million shares of ACADIA Pharmaceuticals In... |
Top 10 Owners of ACADIA Pharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 26.49% | 42,971,927 | 916,591,203 | +1,033,441 | +2.46% |
| The Vanguard Group, Inc. | 8.23% | 13,350,328 | 284,762,496 | +397,162 | +3.07% |
| BlackRock Fund Advisors | 5.16% | 8,370,171 | 178,535,747 | -228,312 | -2.66% |
| RTW Investments LP | 5.08% | 8,242,864 | 175,820,289 | +4,571,926 | +124.54% |
| Fidelity Management & Research Co... | 4.84% | 7,846,446 | 167,364,693 | -1,488,167 | -15.94% |
| EcoR1 Capital, LLC | 3.69% | 5,991,479 | 127,798,247 | 0 | 0.00% |
| SSgA Funds Management, Inc. | 3.44% | 5,586,861 | 119,167,745 | -2,153,477 | -27.82% |
| D. E. Shaw & Co. LP | 3.02% | 4,900,582 | 104,529,414 | +681,183 | +16.14% |
| T. Rowe Price Associates, Inc. (I... | 2.81% | 4,550,906 | 97,070,825 | +271,652 | +6.35% |
| Morgan Stanley & Co. LLC | 2.09% | 3,393,855 | 72,390,927 | +1,061,598 | +45.52% |
Top 10 Mutual Funds Holding ACADIA Pharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF | 2.33% | 3,778,420 | 80,593,699 | +2,273 | +0.06% |
| Vanguard Small Cap Index Fund | 1.96% | 3,177,864 | 67,783,839 | -780 | -0.02% |
| SPDR S&P Biotech ETF | 1.77% | 2,862,618 | 61,059,642 | +50,105 | +1.78% |
| Fidelity Growth Company Fund | 1.59% | 2,581,239 | 55,057,828 | -134,983 | -4.97% |
| iShares Russell 2000 ETF | 1.57% | 2,539,308 | 54,163,440 | -37,120 | -1.44% |
| First Trust NYSE Arca Biotechnolo... | 1.53% | 2,480,452 | 52,908,041 | 0 | 0.00% |
| Government Pension Fund - Global ... | 1.21% | 1,954,156 | 41,682,147 | +875,957 | +81.24% |
| Vanguard Small Cap Growth Index F... | 1.12% | 1,819,871 | 38,817,848 | +7,224 | +0.40% |
| Vanguard Extended Market Index Fu... | 1.02% | 1,654,897 | 35,298,953 | +1,182 | +0.07% |
| T Rowe Price New Horizons Fund | 0.85% | 1,384,071 | 29,522,234 | +63,154 | +4.78% |